epirubicin has been researched along with Peritoneal Carcinomatosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rau, B | 1 |
| Ashley, S; Chau, I; Cunningham, D | 1 |
| Archer, C; Beadman, C; Cunningham, D; Gilligan, D; Kurek, R; Oates, J; Rao, S; Ruhstaller, T; Starling, N; Sumpter, K; Valladares-Ayerbes, M; Wilke, H | 1 |
| Chun, CL; Dormady, S; Eisenstat, S; Lombard, C; Triadafilopoulos, G | 1 |
| Boc, M; Hlebanja, Z; Ocvirk, J; Reberšek, M; Skof, E | 1 |
| Alessandroni, P; Catalano, G; Catalano, V; Fedeli, A; Giordani, P; Graziano, F; Luzi Fedeli, S; Rossi, D; Testa, E | 1 |
| Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB | 1 |
| Fukura, Y; Hatakeyoma, F; Kanno, M; Kikuchi, T; Nakamura, M; Oikawa, K; Saitou, K; Sawada, K; Shibuya, S; Tan, M | 1 |
| Cobellis, L; Di Re, E; Grosso, G; Quattrone, P; Raspagliesi, F | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Maeura, Y; Matsunaga, S; Ohta, H; Okamoto, S; Ueda, N | 1 |
| Hada, T; Hidaka, T; Higashino, K; Moriwaki, Y; Naka, M; Nishigami, T; Takagi, S; Takahashi, S; Yamamoto, T | 1 |
| Hassel, J; Lindemann, F; Slawik, HR; Wagner, T; Wienbeck, M | 1 |
1 review(s) available for epirubicin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
6 trial(s) available for epirubicin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
[Prospective multicentric phase III study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Fluorouracil; Germany; Humans; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prevalence; Risk Factors; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2014 |
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate | 2010 |
Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2012 |
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms | 2002 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
[Home chemotherapy for peritoneal carcinomatosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Home Care Services, Hospital-Based; Home Infusion Therapy; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms | 1994 |
6 other study(ies) available for epirubicin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
Topics: Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Health Status Indicators; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Multicenter Studies as Topic; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2009 |
Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antineoplastic Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Esophageal Achalasia; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Intestinal Polyposis; Liver Neoplasms; Male; Neoplastic Syndromes, Hereditary; Peritoneal Neoplasms; Proton Pump Inhibitors; Taxoids; Trastuzumab | 2011 |
Malignant degeneration in leiomyomatosis peritonealis disseminata.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Leiomyomatosis; Middle Aged; Peritoneal Neoplasms | 1996 |
[A case of malignant fibrous histiocytoma of mesocolon successfully resected after combined chemotherapy with epirubicin, CDDP and vincristine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Histiocytoma, Benign Fibrous; Humans; Male; Mesocolon; Peritoneal Neoplasms; Vincristine | 2000 |
Malignant lymphoma in the mesentery with immune thrombocytopenia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Immunoglobulin G; Lymphoma, Non-Hodgkin; Male; Mesentery; Peritoneal Neoplasms; Platelet Count; Prednisolone; Thrombocytopenia; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1992 |
[Sudden increase in abdominal circumference in a young man].
Topics: Adult; Ascites; Combined Modality Therapy; Diagnosis, Differential; Epirubicin; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Peritoneum | 1991 |